231 results on '"Budd, G. Thomas"'
Search Results
2. A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
3. Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases
4. Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
5. Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
6. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer
7. Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast
8. Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis
9. The utility of repeated cytologic evaluation of cerebrospinal fluid in individuals with metastatic breast cancer
10. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study
11. LATE-ONSET CHOROIDAL METASTASIS FROM BREAST CANCER
12. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
13. Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer
14. Delay to formalin fixation ‘cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
15. Impact of Postmastectomy Radiation on Locoregional Recurrence in Breast Cancer Patients With 1-3 Positive Lymph Nodes Treated With Modern Systemic Therapy
16. Impact of early detection on cancer curability: A modified Delphi panel study.
17. Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial
18. A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer
19. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer
20. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
21. Phase 1 trial of Anvirzel™ in patients with refractory solid tumors
22. Neratinib for Extended Anti-HER2 Therapy in Early Breast Cancer
23. Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma
24. Metronomic therapy for breast cancer
25. Circulating tumor cells, disease progression, and survival in metastatic breast cancer
26. Management of angiosarcoma
27. Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer
28. Phase II Trial of Topotecan by Continuous Infusion in Patients with Advanced Soft Tissue Sarcomas, a SWOG Study
29. Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.
30. Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
31. Unusual macular degeneration following breast cancer
32. Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor–Positive Breast Cancer
33. Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer
34. Role of aromatase inhibitors in the treatment of breast cancer
35. Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
36. A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer
37. Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
38. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival.
39. Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients.
40. Phase I Trial of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Lung Cancer: Clinical and Immunologic Effects
41. Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27
42. Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study.
43. Failed organ preservation strategy for adult laryngeal embryonal rhabdomyosarcoma
44. Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
45. Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center Experience.
46. Can CDK4/6 inhibitors cause fatal lung injury?
47. (OA13) Stereotactic Radiosurgery and Concurrent Targeted Therapy: Improving the Response Rate for Breast Cancer Brain Metastasis
48. Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factor
49. Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer.
50. Specific kinesin expression profiles associated with taxane resistance in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.